# The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding

> **NCT02326922** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ain Shams Maternity Hospital** · enrollment: 61 (actual)

## Conditions studied

- Dysfunctional Uterine Bleeding

## Interventions

- **DEVICE:** Metraplant-E levonorgestrel-releasing intrauterine device

## Key facts

- **NCT ID:** NCT02326922
- **Lead sponsor:** Ain Shams Maternity Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02326922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02326922, "The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02326922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*